The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Novavax Inc. shares fell after the Wall Street Journal reported that US regulators asked the company to conduct another ...

(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...

Novavax shares declined after a Wall Street Journal report that federal regulators are asking the company to complete an additional randomized clinical trial on its Covid-19 vaccine, according to ...

Federal regulators have asked Novavax (NVAX) to conduct another randomized clinical trial of its Covid-19 vaccine following earlier delays in ...

Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...

EDT Novavax (NVAX) asked by FDA to complete additional COVID trial, WSJ saysStay Ahead of the Market: Discover outperforming stocks and ...

On a recent call with analysts at BMO Capital Markets, a “former director” at the FDA’s Center for Biologics Evaluation and ...

Novavax (NASDAQ: NVAX) shares declined 6% following a report from the Wall Street Journal that said federal regulators are ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...